References Alharthy SA, Zughaibi TA, Vij P, Tabrez S, Almashjary MN, Alharthi S, Alamri T, Alghamdi BS, Harakeh S, Azhari SA (2023) Mirtazapine attenuated cadmium-induced neuronal intoxication by regulating Nrf2 and NF-B/TLR4 signals
United States (FDA Classification) MOTSc is not approved by the FDA for human consumption Classified as a research-use-only (RUO) peptide Legal to purchase and possess for non-clinical, non-consumable use Not allowed to be sold as a dietary supplement or labeled for human injection This is the same legal structure shared by other research peptides like BPC157, TB500, and CJC1295
Nausea, vomiting, and diarrhea are consistently the top most common side effects
Accurate information: Our guides provide up-to-date information on legal status, helping you make informed decisions
was supported by the National Institute of Health (1 K22 CA201088-01
Parks, C